Tim West

机构：C2N Diagnostics (United States), Hope Center for Neurological Disorders · ORCID：0000-0003-3267-8249

发表论文 114 篇 · 总被引 4955 次 · h-index 34

代表论文

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care (2024 · JAMA · 被引 365)
Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease (2023 · Alzheimer s & Dementia · 被引 157)
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid (2024 · Alzheimer s & Dementia · 被引 121)
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial (2024 · Alzheimer s & Dementia · 被引 41)
A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment (2023 · Annals of Clinical and Translational Neurology · 被引 33)
PrecivityAD2™ Blood Test: Analytical Validation of an LC-MS/MS Assay for Quantifying Plasma Phospho-tau217 and Non-Phospho-tau217 Peptide Concentrations That Are Used with Plasma Amyloid-β42/40 in a Multianalyte Assay with Algorithmic Analysis for Detecting Brain Amyloid Pathology (2024 · Diagnostics · 被引 17)